Ed Farrell
CEO
Ed brings over 25 years of life science experience gained through senior industry roles with an emphasis on medical devices and diagnostics. Prior to joining LEX Diagnostics Ed was COO of Klay Biotech, and before that he served as President/COO of Quotient Ltd where he led the development and realisation of the MosaiQ platform from concept to commercialisation. He also played a significant role with Quotient’s IPO on Nasdaq. Prior to Quotient, Ed held senior positions in operations in the UK, USA, and Ireland with Siemens Healthcare Diagnostics. He holds a degree in Mechanical Engineering, and a Master’s degree in Engineering Science, from University College Dublin.